The Latest Breaking News from Gavi

The global vaccine alliance Gavi says it will buy 500,000 doses of vaccine against mpox to fight outbreaks of the disease in African countries

The Gavi vaccine alliance has reached an agreement with Danish pharmaceutical company Bavarian Nordic to obtain 500,000 doses of mpox vaccine for African countries dealing with an outbreak of the virus.

Gavi uses newly established First Response Fund to secure doses, but 10 million are needed to meet demand on the continent

African countries produce less than 2 percent of the vaccines the continent needs, experts say.

Nigeria became the first African country this week to receive a batch of vaccines against mpox, a viral disease whose rapid spread led the World Health Organization to declare a global health emergency in mid-August. While more vaccine doses are available, experts say high costs and regulatory hurdles have prevented…

Democratic Republic of the Congo (DRC) hopes to receive its first doses of an mpox vaccine by next week, following promises from the United States and Japan to help it fight its outbreak, the Congolese health minister said on Monday.

Côte d'Ivoire has begun vaccinating children against malaria using a new, affordable vaccine that it's hoped will prove a game changer in the fight against the deadly disease. Several other countries in Africa are expected to roll it out this year.

Initiative announced in Paris will incentivise and offset start-up costs for vaccine manufacturing in the continent.

World leaders, health groups and pharmaceutical firms announced $1.2 billion in funding at a summit Thursday to produce vaccines in Africa, which is facing numerous health crises including rising cholera outbreaks.

World leaders, health groups and pharmaceutical firms announced $1.2 billion in funding at a summit Thursday to produce vaccines in Africa, which is facing numerous health crises including rising cholera outbreaks.

French President Macron launches African Vaccine Manufacturing Accelerator Launched In Paris billion project to boost vaccine access in Africa, addressing disparities highlighted by COVID-19.